(Q54715235)

3 June 2018

title

ERK/p38 MAP-kinases and PI3K are involved in the differential regulation of B7-H1 expression in DC subsets. (English)

1 reference

3 June 2018

author name string

Svetlana Karakhanova

1

1 reference

3 June 2018

Stefan Meisel

2

1 reference

3 June 2018

Sabine Ring

3

1 reference

3 June 2018

Karsten Mahnke

4

1 reference

3 June 2018

Alexander H Enk

5

1 reference

3 June 2018

language of work or name

English

0 references

publication date

1 January 2010

1 reference

3 June 2018

European Journal of Immunology

published in

1 reference

3 June 2018

volume

40

1 reference

3 June 2018

issue

1

1 reference

3 June 2018

page(s)

254-266

1 reference

3 June 2018

Costimulating aberrant T cell responses by B7-H1 autoantibodies in rheumatoid arthritis

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939289

B7-H1 pathway and its role in the evasion of tumor immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939289

Blockade of B7-H1 on macrophages suppresses CD4+ T cell proliferation by augmenting IFN-gamma-induced nitric oxide production

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939289

Blockade of B7-H1 Suppresses the Development of Chronic Intestinal Inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939289

Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939289

B7-H1 is expressed by human endothelial cells and suppresses T cell cytokine synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939289

B7-H1 (programmed death-1 ligand) on dendritic cells is involved in the induction and maintenance of T cell anergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939289

Tolerogenic dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939289

7 January 2021

Induction of tolerogenic DCs: 'you are what you eat'.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939289

7 January 2021

Regulation of T cell immunity by dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939289

7 January 2021

Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939289

7 January 2021

Induction of CD4+/CD25+ regulatory T cells by targeting of antigens to immature dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939289

7 January 2021

Expression of the programmed death ligand 1, B7-H1, on gastric epithelial cells after Helicobacter pylori exposure promotes development of CD4+ CD25+ FoxP3+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939289

7 January 2021

B7-H1 up-regulation on myeloid dendritic cells significantly suppresses T cell immune function in patients with chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939289

7 January 2021

Expression of B7-H1 in inflammatory renal tubular epithelial cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939289

7 January 2021

B7-H1 up-regulated expression in human pancreatic carcinoma tissue associates with tumor progression

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939289

7 January 2021

The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic factors.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939289

7 January 2021

Microglial expression of the B7 family member B7 homolog 1 confers strong immune inhibition: implications for immune responses and autoimmunity in the CNS.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939289

7 January 2021

The B7 family revisited

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939289

7 January 2021

PD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939289

7 January 2021

In a model of tumor dormancy, long-term persistent leukemic cells have increased B7-H1 and B7.1 expression and resist CTL-mediated lysis.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939289

7 January 2021

The balance of immune responses: costimulation verse coinhibition

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939289

7 January 2021

Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939289

7 January 2021

Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939289

7 January 2021

Mouse and human dendritic cell subtypes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939289

7 January 2021

PD-1/PD-L1, but not PD-1/PD-L2, interactions regulate the severity of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939289

7 January 2021

The PD-1/PD-L pathway is up-regulated during IL-12-induced suppression of EAE mediated by IFN-gamma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939289

7 January 2021

Delivering PD-1 inhibitory signal concomitant with blocking ICOS co-stimulation suppresses lupus-like syndrome in autoimmune BXSB mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939289

7 January 2021

PD-1 ligands expressed on myeloid-derived APC in the CNS regulate T-cell responses in EAE.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939289

7 January 2021

Differential role of programmed death-ligand 1 [corrected] and programmed death-ligand 2 [corrected] in regulating the susceptibility and chronic progression of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939289

7 January 2021

Intrahepatic expression of the co-stimulatory molecules programmed death-1, and its ligands in autoimmune liver disease.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939289

7 January 2021

B7-H1 restricts neuroantigen-specific T cell responses and confines inflammatory CNS damage: implications for the lesion pathogenesis of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939289

7 January 2021

Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939289

7 January 2021

Human muscle cells express a B7-related molecule, B7-H1, with strong negative immune regulatory potential: a novel mechanism of counterbalancing the immune attack in idiopathic inflammatory myopathies

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939289

7 January 2021

NK cells that are activated by CXCL10 can kill dormant tumor cells that resist CTL-mediated lysis and can express B7-H1 that stimulates T cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939289

7 January 2021

Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939289

7 January 2021

Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939289

7 January 2021

B7-H1 is up-regulated in HIV infection and is a novel surrogate marker of disease progression

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939289

7 January 2021

Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939289

7 January 2021

Dendritic cells infiltrating human non-small cell lung cancer are blocked at immature stage

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939289

7 January 2021

Effect of intrauterine HIV-1 exposure on the frequency and function of uninfected newborns' dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939289

7 January 2021

Toll-like receptor control of the adaptive immune responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939289

7 January 2021

The signaling adaptors and pathways activated by TNF superfamily

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939289

7 January 2021

Principles of interleukin (IL)-6-type cytokine signalling and its regulation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939289

7 January 2021

Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939289

7 January 2021

Prostaglandin E2 induced functional expression of early growth response factor-1 by EP4, but not EP2, prostanoid receptors via the phosphatidylinositol 3-kinase and extracellular signal-regulated kinases

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939289

7 January 2021

Toll-like receptor function and signaling

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939289

7 January 2021

Toll-like receptor signalling

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939289

7 January 2021

IFN-gamma regulates the expression of B7-H1 in dermal fibroblast cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939289

7 January 2021

Plasma cells from multiple myeloma patients express B7-H1 (PD-L1) and increase expression after stimulation with IFN-{gamma} and TLR ligands via a MyD88-, TRAF6-, and MEK-dependent pathway.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939289

7 January 2021

Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939289

7 January 2021

Regulation of PD‐1, PD‐L1, and PD‐L2 expression during normal and autoimmune responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939289

7 January 2021

Immunology of B7-H1 and its roles in human diseases

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939289

7 January 2021

Blocking of monocyte-associated B7-H1 (CD274) enhances HCV-specific T cell immunity in chronic hepatitis C infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939289

7 January 2021

Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939289

7 January 2021

B7-H1 up-regulation impairs myeloid DC and correlates with disease progression in chronic HIV-1 infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939289

7 January 2021

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939289

7 January 2021

Proliferating dendritic cell progenitors in human blood

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939289

7 January 2021

Identifiers

DOI

10.1002/EJI.200939289

1 reference

3 June 2018

PubMed ID

19830728

1 reference

3 June 2018